This can explain the antitumorigenic effects of HIF-1α in cancers with low MYC oncogenic dependency and demonstrates the complexity of HIF-α in highly MYC oncogenic cancers, suggesting that solely inhibiting HIF-1α may result in preliminary attenuation, but have no impact on overall tumor burden [273]. The gene discussed is MYC; the disease is neoplasm.